Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Diabetes Mellitus
Once Weekly Exenatide is Safe and Effective for Long-term T2DM Treatment
Effects of PDE-5 Inhibition in Patients with T2DM
Novel Once-Weekly Omarigliptin as Effective and Well Tolerated as Once-Daily Sitagliptin in Japanese Patients
SGLT2 Inhibitors: A Comprehensive Evaluation of Mechanism of Action, Place in Therapy, and Urogenital Tolerability
Combined Saxagliptin and Dapagliflozin Reduce Blood Glucose Levels in T2DM Patients
Exploring the Value and Costs of Incretin-Based Therapies
Combining Empagliflozin and Linagliptin with Metformin Reduces HbA
1c
in Patients with T2DM
Key Advances in Understanding the Pathogenesis of Diabetes
Empagliflozin Superior to Glimepiride as Second-line Treatment in T2DM
Genetics Can Unravel the Pathogenesis of Diabetes
Pages
Previous
Next
1
2
3
4
5
6
7
8
9
…
12
